Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,828,003Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1LGM Pharma

02 1ALP Pharm

03 1Chongqing Huapont Pharmaceutical

04 1DISHMAN NETHERLANDS B.V.

05 1Dishman Carbogen Amcis

06 1DongWha Pharm

07 1Formosa Laboratories

08 1Hanways Chempharm

09 1Haoyuan Chemexpress Co.Ltd

10 1Sichuan Gowell Pharmaceutical

11 1Teva API

12 1Teva Pharmaceutical Industries

13 1Zhejiang Ausun Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Paricalcitol

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

ALP Pharm

China
2024 ACI Convention
Not Confirmed
arrow

ALP Pharm

China
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts...

ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts in the USA, United Kingdom, and India have more than 10 years of Western cGMP experience. Prior to working for ALP Pharm, they have helped more than 30 pharmaceutical companies achieve ANDAs and DMFs and also helped some branded companies to pass FDA inspections for the NDA and IND. Meanwhile, they helped some European pharmaceutical companies to get licenses for finished drugs including oral solid dosages and injections, as well as COSs and EDMFs.
blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innov...

Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innovative enterprise, and a national demonstration enterprise for a new model of intelligent manufacturing. It has a national enterprise technology center and multiple municipal R&D platforms, two formulation factories, and two API factories. In addition, the company is also widely involved in the fields of respiratory, cardiovascular and cerebrovascular, blood, tumor, and systemic hormones, and has accumulated a large number of blockbuster drugs.
blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...

We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to market while improving the lives of their patients across the world. Our objective is to help our customers create a better world as the partner of choice to develop and manufacture complex and challenging substances, highly potent active ingredients, and breaking new ground with innovative vitamin, healthcare, and industrial products.
blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : DISHMAN Netherlands is located in Veenendaal in the middle of the Netherlands. We are active in the marketing/sales and manufacture of Vitamin D analogues, Vitamin D, Cholesterol a...

DISHMAN Netherlands is located in Veenendaal in the middle of the Netherlands. We are active in the marketing/sales and manufacture of Vitamin D analogues, Vitamin D, Cholesterol and lanolin related products for key markets as pharmaceutical, cosmetic, feed, food, shrimp farming and industry applications. Our Vitamin D analogue products include: Alfacalcidol, Calcifediol, Calcitriol, & Dihydrotachysterol-2. These analogues are used in pharmaceutical products to combat Osteoporosis, rickets etc. Vitamin D2 and D3 are manufactured for use in the food, feed and pharmaceutical industries. Cholesterol is used in diverse applications such as drug d
blank

06

DongWha Pharm

South Korea
2024 ACI Convention
Not Confirmed
arrow

DongWha Pharm

South Korea
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : DongWha is the company that "serves customers by making good medicines and is managed with the rewards generated by benefits of good medicines." Under its corporate philosophy that...

DongWha is the company that "serves customers by making good medicines and is managed with the rewards generated by benefits of good medicines." Under its corporate philosophy that places the foremost priority on health and safety of its customers, it continues to work toward happiness of customers. Based on respect for the shared value that "we work diligently in our youth and live fruitful lives in old age." it serves every customer faithfully by fostering ownership and faith among its members.
blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Formosa Laboratories Inc. founded in Taiwan since 1995 started with API business and has been serving customers worldwide. As an established API manufacturer receiving GMP inspecti...

Formosa Laboratories Inc. founded in Taiwan since 1995 started with API business and has been serving customers worldwide. As an established API manufacturer receiving GMP inspections from regulatory authorities around the world, Formosa now provides CDMO service extending from APIs and ADCs (Antibody Drug Conjugates) to cytotoxic and non-cytotoxic injectables of aseptic liquid filling and lyophilization. Formosa Laboratories is able to offer full-service GMP manufacturing for drug substance, ADCs and drug product with its API and injectable facilities that accommodates small molecules, biologics and ADCs etc.
blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...

Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediates, and fine chemicals for worldwide markets. With decades of development, now we grow to a leading and outstanding company. We are not just a trading company, but a comprehensive solutions supplier. With our sound knowledge of pharmaceutical business, our advantage is to integrate resources and adapt to all different demands of markets. We are a young but dynamic and energetic company with high efficient and high flexible decision making system.
blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical interm...

Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical intermediates and new drugs. The company is mainly engaged in customized synthesis of complex small molecule frameworks and pharmaceutical intermediates, and independent R&D of innovative new drugs; and provides services of production technology improvement and consigned new drug development for pharmaceutical enterprises. Haoyuan Chemexpress is committed to researching and developing APIs and pharmaceutical intermediates with high synthesis technology barriers and difficulties and high added value, and also focuses on the synthesis of chiral compounds.
blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Ph...

Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Pharmaceutical Co., Ltd., and Shanghai Ocuen Biotechnology Co., Ltd. After years of development, Guowei Pharmaceutical has developed into a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. Guowei Pharmaceutical's research and development and sales of products are mainly concentrated in the fields of cardiovascular and cerebrovascular, digestive system, anti-infection, and urinary system.
blank

11

Teva API

Israel
2024 ACI Convention
Not Confirmed
arrow

Teva API

Israel
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Teva API is a standalone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer. Employing over 4,000 professionals at 15 internationa...

Teva API is a standalone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer. Employing over 4,000 professionals at 15 international plant sites and 6 R&D centers, Teva API is a leading international supplier of active pharmaceutical ingredients (APIs) with the industry’s broadest portfolio of over 350 products. Its leadership in cutting-edge development, large-scale production capacity and global support make it an ideal API partner of choice. Over its more than 85 years of existence, Teva API has acquired and established top-rated manufacturing and development facilities around the world.
blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Paricalcitol

About the Company : Founded in 2010, Ausun Pharmaceutical is a public company, specialized in high-tech. threshold Generic API Dev. & providing CDMO services. Ausun owns & operates 1 on-site R&D Cente...

Founded in 2010, Ausun Pharmaceutical is a public company, specialized in high-tech. threshold Generic API Dev. & providing CDMO services. Ausun owns & operates 1 on-site R&D Center & 1 Mfg. Site which has been certified by US FDA, JPMDA & EMA, supported by >550 highly trained professionals across departments & >200 scientists to bring high quality products to customers. More than 130 products/projects have been successfully developed since founded. Process Innovation, R&D Efficiency & Cost Effectiveness are Ausun's key competencies. Create Chemistry and to be the 1st Class Worldwide Pharmaceutical Corporation is our goal.
blank

Paricalcitol Manufacturers | Traders | Suppliers

Paricalcitol Manufacturers, Traders, Suppliers 1